Aims: Recurrent in-stent restenosis (RISR) represents a series of repeated cardiac ischemic events post-successful revascularization, associated with exceedingly huge disease burden without effective pharmacologic therapies. Neointimal hyperplasia (NIH) is recognized as the primary biological driver...
ORGANISM(S): Homo sapiens